Macrophage Activation Syndrome (MAS) Market

Macrophage Activation Syndrome Epidemiology Segmentation

The epidemiology section of the report offers detailed historical and projected insights into the MAS patient population across key markets. MAS affects both pediatric and adult demographics — occurring most commonly in children with sJIA and Kawasaki disease (KD), while adult cases are more frequently observed in AOSD, systemic lupus erythematosus (SLE), and secondary triggers such as infections or malignancies.

The report provides comprehensive epidemiological analysis for the 2020–2034 study period across leading markets, segmented by:

• Total Diagnosed Prevalent Population of SLE
• Total Diagnosed Prevalent Population of AOSD
• Total Diagnosed Prevalent Population of sJIA
• Total Incident Population of Kawasaki Disease
• Total Diagnosed Prevalent Population of MAS
• Gender-specific Diagnosed Prevalent Population of MAS
• Total Treated Cases of MAS

Macrophage Activation Syndrome Market Report Key Metrics

Report Scope

• Therapeutic Assessment: Comprehensive review of currently marketed and pipeline MAS therapies
• Market Dynamics: Key forecast assumptions for emerging MAS drugs and overall market outlook
• Competitive Intelligence: SWOT analysis and market entry strategies
• Unmet Needs: Expert KOL perspectives, analyst viewpoints, and market access and reimbursement analysis

Download the report to understand the latest research on macrophage activation syndrome @ New Macrophage Activation Syndrome Medication - https://www.delveinsight.com/report-store/macrophage-activation-syndrome-market?utm_source=apac&utm_medium=promotion&utm_campaign=akpr 

Table of Contents

1. Macrophage Activation Syndrome Market Key Insights
2. Macrophage Activation Syndrome Market Report Introduction
3. Executive Summary of Macrophage Activation Syndrome (MAS)
4. Key Events
5. Epidemiology and Market Forecast Methodology
6. MAS Market Overview at a Glance
7. • 6.1 Clinical Landscape (Analysis by Molecule Type, Phase, and Route of Administration)
   • 6.2 MAS Therapy Market Share (%) in the 6MM — 2024
   • 6.3 MAS Therapy Market Share (%) in the 6MM — 2034
8. Disease Background and Overview
9. • 7.1 Introduction
   • 7.2 MAS-Associated Diseases (AOSD, sJIA, SLE, Kawasaki Disease)
   • 7.3 Symptoms
   • 7.4 Major Triggers of sHLH
   • 7.5 Pathogenesis
   • 7.6 Diagnosis
   • 7.7 Diagnostic Guidelines
10. Macrophage Activation Syndrome Treatment
11. Epidemiology and Patient Population
12. • 9.1 Key Findings
    • 9.2 Assumptions and Rationale
    • 9.3–9.6 Diagnosed Prevalent Populations (SLE, AOSD, sJIA, Kawasaki Disease) in the 7MM
    • 9.7 Total Diagnosed Prevalent Population of MAS in the 7MM
    • 9.8 United States (MAS Prevalence, Gender Distribution, Treated Cases)
    • 9.9 EU4 and the UK
    • 9.10 Japan
13. Macrophage Activation Syndrome Patient Journey
14. Marketed Macrophage Activation Syndrome Therapies
15. • 11.1 Marketed Therapy Details
    • 11.2 Emapalumab-lzsg (GAMIFANT) — Sobi (Product Description, Regulatory Milestones, Pivotal Trials, Analyst Views)
16. Emerging Macrophage Activation Syndrome Drugs
17. • 12.1 Key Cross Competition
    • 12.2 ELA026 — Electra Therapeutics
    • 12.3 Plonmarlimab (TJM2/TJ003234) — TJ Biopharma/I-Mab Biopharma (NovaBridge Biosciences)
    • 12.4 Tadekinig Alfa (r-hIL-18BP) — AB2 Bio
    • 12.5 MAS825 — Novartis
    • 12.6 Tocilizumab (Actemra/RoActemra) — Chugai Pharmaceutical
18. MAS Market: 7MM Analysis
19. • 13.1 Key Findings
    • 13.2 Market Outlook
    • 13.3 Conjoint Analysis
    • 13.4 Key Forecast Assumptions
    • 13.5 Total MAS Market Size in the 7MM
    • 13.6 United States Market (Total and by Therapies)
    • 13.7 EU4 and UK Market Size
    • 13.8 Japan Market Size
20. Macrophage Activation Syndrome Market Unmet Needs
21. Macrophage Activation Syndrome Market SWOT Analysis
22. KOL Perspectives on Macrophage Activation Syndrome
23. Market Access and Reimbursement (US, EU4 & UK, Japan)
24. Asia-Pacific Regional Landscape (Japan, South Korea, Taiwan)
25. Bibliography
26. Report Methodology

Related Market Reports

Systemic Lupus Erythematosus Market

Market Insights, Epidemiology, and Forecast — 2034. This report provides a detailed understanding of SLE, including historical and projected epidemiology, individual therapy market shares, and key companies such as Biogen, Novartis, MorphoSys, Idorsia Pharmaceuticals, Viatris, RemeGen, UCB Pharma, Genentech, Bristol Myers Squibb, AbbVie, and others.

Adult-Onset Still's Disease Market

Market Insights, Epidemiology, and Forecast — 2034. This report covers AOSD comprehensively, with epidemiological data, therapy market shares, and profiles of leading companies including Novartis, Swedish Orphan Biovitrum, Roche, Cerecor, AB2 Bio Ltd, and others.

Juvenile Idiopathic Arthritis Market

Market Insights, Epidemiology, and Forecast — 2034. This report delivers detailed analysis of JIA, encompassing epidemiological trends, individual therapy market shares, and key companies such as Regeneron, Sanofi, AbbVie, Eli Lilly and Company, Incyte Corporation, Johnson & Johnson, Hope Biosciences, Bristol-Myers Squibb, UCB Biopharma, Novartis, and others.

Kawasaki Disease Market

Market Insights, Epidemiology, and Forecast — 2034. This report provides comprehensive insights into Kawasaki disease, covering epidemiology, therapy market shares, and profiles of key companies including Green Cross Corporation, GC Biopharma Corp, Mitsubishi Tanabe Pharma Corporation, Centocor Inc., Amgen, Takeda, The Emmes Company LLC, and others.

About DelveInsight

DelveInsight is a premier healthcare-focused market research and consulting firm committed to delivering superior market intelligence and strategic analysis for well-informed business decisions. Backed by a team of seasoned industry specialists with extensive expertise across the life sciences and healthcare sectors, DelveInsight provides customized research solutions and actionable insights to organizations worldwide. Connect with us to access high-quality, accurate, and real-time intelligence that positions you ahead of the growth curve.

Media Contact 

Company Name: DelveInsight Business Research LLP